HLAVSA, Jan, F. CECKA, P. ZARUBA, J. ZAJAK, R. GURLICH, R. STRNAD, Tomáš PAVLÍK, Zdeněk KALA and M. LOVECEK. Tumor grade as significant prognostic factor in pancreatic cancer: validation of a novel TNMG staging system. Neoplasma. Bratislava: Slovenská akademie vied, vol. 65, No 4, p. 637-643. ISSN 0028-2685. doi:10.4149/neo_2018_171012N650. 2018.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Tumor grade as significant prognostic factor in pancreatic cancer: validation of a novel TNMG staging system
Authors HLAVSA, Jan (203 Czech Republic, belonging to the institution), F. CECKA (203 Czech Republic), P. ZARUBA (203 Czech Republic), J. ZAJAK (203 Czech Republic), R. GURLICH (203 Czech Republic), R. STRNAD (203 Czech Republic), Tomáš PAVLÍK (203 Czech Republic, belonging to the institution), Zdeněk KALA (203 Czech Republic, belonging to the institution) and M. LOVECEK (203 Czech Republic, guarantor).
Edition Neoplasma, Bratislava, Slovenská akademie vied, 2018, 0028-2685.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30204 Oncology
Country of publisher Slovakia
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 1.771
RIV identification code RIV/00216224:14110/18:00106969
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.4149/neo_2018_171012N650
UT WoS 000440172400019
Keywords in English pancreatic cancer; grade; TNM classification; prognosis
Tags 14110223, 14119612, rivok
Tags International impact, Reviewed
Changed by Changed by: Soňa Böhmová, učo 232884. Changed: 12/2/2019 16:49.
Abstract
Aim of the study was to asses the tumor grade prognostic value in the Czech pancreatic cancer patients and to evaluate the accuracy of TNMG prognostic model. Retrospective analysis of 431 pancreatic cancer patients undergoing pancreatic resection in seven Czech oncological centers between 2003 and 2013 was performed. The impact of tumor grade and the accuracy of TNMG prognostic model were evaluated. Lymph node status, tumor size, tumor stage and grade were proved as statistically significant survival predictors. The lower tumor differentiation (grade 3 and 4) was associated with poorer prognosis in all stages (stage I: HR 2.23 [1.14; 4.36, CI 95%] p=0.019, stage II: HR 3.09 [2.01; 4.77, CI 95%] p=0.001, stage III and IV: HR 3.52 [1.73; 7.18, CI 95%] p=0.001). Kaplan-Meier analysis verified statistically significant impact of new TNMG stages on survival after resection for pancreatic cancer (p=0.001). In conclusion, we can state that the tumor grade was confirmed as statistically significant prognostic factor in pancreatic cancer. Its incorporation into the current TNM classification enables more accurate prognosis prediction within particular clinical stages. That is why an inclusion of the grade to the standard TNM classification should be discussed.
Links
NV16-31314A, research and development projectName: Identifikace cirkulujících mikroRNA umožňujících prognostickou stratifikaci a selekci pacientů nejvíce profitujících z chirurgické léčby
PrintDisplayed: 20/4/2024 02:29